Boston Scientific Corp (BSX) concluded trading on Wednesday at a closing price of $95.95, with 10.74 million shares of worth about $1.03 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 24.43% during that period and on January 08, 2025 the price saw a gain of about 4.30%. Currently the company’s common shares owned by public are about 1.47B shares, out of which, 1.47B shares are available for trading.
Stock saw a price change of 7.42% in past 5 days and over the past one month there was a price change of 6.53%. Year-to-date (YTD), BSX shares are showing a performance of 7.42% which increased to 64.24% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $57.77 but also hit the highest price of $92.42 during that period. The average intraday trading volume for Boston Scientific Corp shares is 5.68 million. The stock is currently trading 6.07% above its 20-day simple moving average (SMA20), while that difference is up 7.64% for SMA50 and it goes to 19.77% higher than SMA200.
Boston Scientific Corp (NYSE: BSX) currently have 1.47B outstanding shares and institutions hold larger chunk of about 91.26% of that.
The stock has a current market capitalization of $141.41B and its 3Y-monthly beta is at 0.79. PE ratio of stock for trailing 12 months is 79.36, while it has posted earnings per share of $1.21 in the same period. Its PEG reads 5.59 and has Quick Ratio of 1.02 while making debt-to-equity ratio of 0.54. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BSX, volatility over the week remained 1.75% while standing at 1.69% over the month.
Stock’s fiscal year EPS is expected to rise by 20.15% while it is estimated to increase by 13.79% in next year. EPS is likely to grow at an annualized rate of 14.20% for next 5-years, compared to annual growth of -2.05% made by the stock over the past 5-years.
Coverage by Goldman stated Boston Scientific Corp (BSX) stock as a Buy in their note to investors on May 30, 2024, suggesting a price target of $90 for the stock. On February 01, 2024, Mizuho Upgrade their recommendations, while on July 19, 2023, Robert W. Baird Initiated their ratings for the stock with a price target of $59. Stock get a Buy rating from CL King on June 30, 2023.
